News

Castle Biosciences Announces the Appointment of Bernhard E. Spiess as Chief Operating Officer

Friendswood, TX – May 9, 2016

Independent Study Verifies the Performance of Castle Biosciences’ Cutaneous Melanoma Gene Expression Profile Test for Predicting Risk of Metastasis

Friendswood, TX – May 2, 2016

Navigating Cancer and the Center for Cancer and Blood Disorders Partner to Deliver a New Triage Pathways Solution for Patient-Centered Care

Fort Worth, TX and Seattle, WA – March 8, 2016

Bioventus Introduces New Products for Spine Surgery, Osteoarthritis at AAOS

Orlando, FL – March 2, 2016

Carolina Pines Regional Medical Center’s Hospitalist Group Joins Forces With Nationally-Recognized HNI Healthcare

Hartsville, SC – February 1, 2016

Honorable James Greenwood, CEO of BIO, Presented with 2015 Spindletop Capital Healthcare Achievement Award

Houston, TX – October 5, 2015

Hospitalists Now Inc. Changes Name to HNI Healthcare

Austin, TX – October 2, 2015

Bioventus Launches Online Center for Orthobiologic Learning, Bioventus Academy

Durham, NC – September 8, 2015

QSpex Named a TAG Top 10 Innovative Tech

Atlanta, GA – March 11, 2015

Spindletop Capital Announces 2013 Spindletop Healthcare Index Results

Austin, TX – April 1, 2014

Spindletop Capital Announces Addition of Dr.Kelly Huang As Operating Partner

Austin, TX – February 19, 2014

Spindletop Capital Announces Two Executive Promotions; Steve Whitlock and Bob McDonald, MD, MBA Promoted to Managing Director

Austin, TX – January 13, 2014

Dr. Evan Melrose Becomes a Prestigious NACD Fellow

Austin, TX – December 23, 2013

Anthony P. Bihl III Named New Bioventus Chief Executive Officer

Durham, NC – November 21, 2013

Spindletop Capital Congratulates The 2013 Texas Business Hall of Fame Inductees

Austin, TX – November 13, 2013

Bioventus Names Alessandra Pavesio New Chief Science Officer

Durham, NC – July 11, 2013

Bioventus Announces European Launch of Next Generation EXOGEN® Device

Hoofddorp, Netherlands – July 4, 2013

Bioventus Acquires Exclusive Rights to Pfizer’s BMP Portfolio

Durham, NC – July 1, 2013

Bioventus Launches Company in Australia and Poland

Hoofddorp, Netherlands – July 1, 2013

NTAC Releases Adoption Pack to Assist Implementation of NICE Guidelines Supporting the Use of EXOGEN®

Hoofddorp, Netherlands – May 13, 2013

Bioventus Opens Operations in Germany

Hoofddorp, Netherlands – May 6, 2013

The Texas Lyceum’s 26th Public Conference Healthcare Innovation: The Next Spindletop for Texas?

Houston, TX – October 18, 2012

QSpex Technologies Secures approximately $20.5 Million in Series D Funding; Appoints Dr. Melrose New Director

Alpharetta, GA – June 7, 2012

New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing

Durham, NC – May 7, 2012

The Cancer Prevention and Research Institute of Texas (CPRIT) announces partnership with Texas BioAlloance and Spindletop Healthcare Capital posied to bring life-saving treatment and jobs to Texas

Austin, TX – March 20, 2012

Spindletop Capital attends Alzheimer’s Drug Discovery Foundation (ADDF) Symposium in New York

Austin, TX – September 21, 2011